NuSkin Enterprises (NUS)

NYSE Piyasa kapalı

Nu Skin Enterprises, Inc. is a global beauty and wellness company that develops, markets, and sells personal care products, nutritional supplements, and related consumer technologies. The company is best known for the Nu Skin brand, which spans skin care, beauty devices, and anti-aging products, and Pharmanex, its wellness and nutrition line. Its products are distributed internationally through a direct selling model supported by independent sales leaders, social commerce tools, and local market operations.

Nu Skin reports its business across a broad geographic footprint that includes the Americas, Mainland China, Southeast Asia/Pacific, Japan, South Korea, Europe & Africa, and Hong Kong/Taiwan. This structure reflects the company’s reliance on local consumer preferences, regulatory environments, and distributor networks in each region. The Americas segment is a particularly important contributor, and wellness products represent a major part of total revenue.

Beyond its core branded consumer business, Nu Skin operates Rhyz, a strategic investment and operating platform. Rhyz includes manufacturing and packaging assets that support product development and supply chain capabilities, as well as other investments intended to broaden the company’s commercial reach. This gives Nu Skin exposure not only to consumer-facing beauty and wellness categories, but also to parts of the production infrastructure behind them.

The company competes in markets shaped by health-conscious consumers, premium skin care demand, and the growth of digital selling. Its performance depends on product innovation, brand engagement, distributor productivity, and the ability to navigate changing rules for direct selling and consumer products across global markets.

5.37 USD
5.19 USD
+0.05 (+0.94%)
Mesai sonrası

Son güncelleme

Piyasa değeri
260.72M
F/K
4.78
F/SNF
6.27
F/S
0.18
Firma değeri
285.66M
Sektör
Health Care
Sektör altı
Drugs, Drug Proprietaries, and Druggists' Sundries
Adres
75 WEST CENTER ST, PROVO, UT, 84601
GlobeNewswire Inc.

Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%

10 Eyl 2024, 01:00 ÖÖ
Zacks Investment Research

Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?

07 Haz 2024, 18:30 ÖS
Zacks Investment Research

Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes

09 May 2024, 17:23 ÖS
Zacks Investment Research

Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates

09 May 2024, 02:00 ÖÖ
Zacks Investment Research

Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?

28 Mar 2024, 18:30 ÖS
Zacks Investment Research

Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?

15 Mar 2024, 18:30 ÖS
Zacks Investment Research

Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y

15 Şub 2024, 15:51 ÖS
Zacks Investment Research

Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates

15 Şub 2024, 02:20 ÖÖ
Zacks Investment Research

Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings

12 Şub 2024, 15:49 ÖS
Zacks Investment Research

Philip Morris (PM) Lags Q4 Earnings Estimates

08 Şub 2024, 16:15 ÖS
Zacks Investment Research

Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for

07 Şub 2024, 18:00 ÖS
Zacks Investment Research

Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why

13 Ara 2023, 20:50 ÖS
Zacks Investment Research

Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?

07 Ara 2023, 19:31 ÖS
Zacks Investment Research

Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?

01 Ara 2023, 19:32 ÖS
Zacks Investment Research

Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance

02 Kas 2023, 18:44 ÖS
Zacks Investment Research

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

30 Eki 2023, 19:10 ÖS
Zacks Investment Research

e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?

30 Eki 2023, 18:05 ÖS
Zacks Investment Research

Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings

30 Eki 2023, 16:06 ÖS
Zacks Investment Research

Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth

25 Eki 2023, 17:02 ÖS
Zacks Investment Research

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

10 Eki 2023, 16:10 ÖS
Piyasa değeri
260.72M
Firma değeri
285.66M
F/K
4.78
F/DD
0.33
F/S
0.18
FD / FAVÖK
2.17
FD / satışlar
0.2
Hisse başına kazanç
1.12
Temettü verimi
6.98%
F/SNF
6.27
F/NF
3.43
Serbest nakit akışı
41.57M
Özkaynak karlılığı
6.87%
Aktif karlılığı
3.96%
Borç / özkaynak
0.28
Cari oran
2.03
Asit-test oranı
1.34
Nakit
0.77
Ort. hacim
649.56K
Temel gösterge anlık fiyatı
5.37

Gelir tablosu

Kalem 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Gelir 320.61M 370.32M 364.21M 386.14M 364.49M
Brüt kâr 214.46M 261.98M 256.72M 265.73M 246.96M
Faaliyet kârı 4.03M 23.24M 21.64M 30.78M -9.9M
FAVÖK 18.21M 36.16M 33.73M 43.83M 29.42M
Net kâr 1.84M 14.49M 17.08M 21.12M 107.52M
Temel EPS 0.04 0.31 0.35 0.43 2.16
Seyreltilmiş EPS 0.04 0.27 0.34 0.43 2.14

Bilanço

Kalem 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Toplam varlıklar 1.38B 1.41B 1.42B 1.44B 1.39B
Toplam yükümlülükler 582.71M 600.07M 624.61M 655.94M 637.44M
Özkaynak 794.09M 805.24M 799.8M 787.75M 753.97M
Nakit ve benzerleri 198.65M 238.63M 251.79M 264.16M 203.77M
Dönen varlıklar 522.89M 547.7M 548.14M 571.55M 524.86M
Kısa vadeli yükümlülükler 257M 263.73M 254.44M 283.91M 260.3M

Nakit akışı

Kalem 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Faaliyet nakit akışı -3.92M 16.62M 27.48M 35.8M 389K
Yatırım nakit akışı -14.29M -9.76M -9.92M 8.79M 181.54M
Finansman nakit akışı -20.4M -18.5M -26.88M 9.27M -166.3M
Nakit değişimi -39.98M -13.16M -12.37M 60.39M 16.89M
Tür Bildirim Tarih Bağlantı
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 144 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
form 4 Form 4 — Winett James M Bildirimi görüntüle
edgar index S-8 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 144 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
form 4 Form 4 — CAMPBELL DANIEL W Bildirimi görüntüle
form 4 Form 4 — CAMPBELL DANIEL W Bildirimi görüntüle
form 4 Form 4 — CAMPBELL DANIEL W Bildirimi görüntüle
form 4 Form 4 — Thomas Pisano R. Bildirimi görüntüle
form 4 Form 4 — Battle Emma S. Bildirimi görüntüle
form 4 Form 4 — WOODBURY EDWINA D Bildirimi görüntüle
form 4 Form 4 — WOODBURY EDWINA D Bildirimi görüntüle
form 4 Form 4 — Zorko Mark A Bildirimi görüntüle
form 4 Form 4 — Nathanson Laura Bildirimi görüntüle
form 4 Form 4 — Winett James M Bildirimi görüntüle
edgar index 8-K — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
eight k text 8-K — 8-K Bildirimi görüntüle
edgar index SD — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 144 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
form 4 Form 4 — Nathanson Laura Bildirimi görüntüle
edgar index 10-Q — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 8-K — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
eight k text 8-K — 8-K Bildirimi görüntüle
edgar index 8-K — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
eight k text 8-K — 8-K Bildirimi görüntüle
edgar index DEF 14A — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index DEFA14A — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index ARS — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 3 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
form 3 Form 3 — Lantz Chelsea K Bildirimi görüntüle
edgar index SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 8-K — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
eight k text 8-K — 8-K Bildirimi görüntüle
edgar index 8-K — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
eight k text 8-K — 8-K Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
form 4 Form 4 — WOODBURY EDWINA D Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 8-K — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
eight k text 8-K — 8-K Bildirimi görüntüle
form 4 Form 4 — NAPIERSKI RYAN S Bildirimi görüntüle
form 4 Form 4 — Thomas James D Bildirimi görüntüle
form 4 Form 4 — Clark Chayce David Bildirimi görüntüle
form 4 Form 4 — Hatchett Steven Keith Bildirimi görüntüle
form 4 Form 4 — Keisel Justin S Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
form 4 Form 4 — NAPIERSKI RYAN S Bildirimi görüntüle
form 4 Form 4 — Thomas James D Bildirimi görüntüle
form 4 Form 4 — Clark Chayce David Bildirimi görüntüle
form 4 Form 4 — Hatchett Steven Keith Bildirimi görüntüle
form 4 Form 4 — Keisel Justin S Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
edgar index 4 — NU SKIN ENTERPRISES, INC. Bildirimi görüntüle
form 4 Form 4 — NAPIERSKI RYAN S Bildirimi görüntüle
form 4 Form 4 — Thomas James D Bildirimi görüntüle
form 4 Form 4 — Clark Chayce David Bildirimi görüntüle